E007 Is there an urgent need to change the methotrexate monitoring guidelines to incorporate fibroscan?
Sign Up to like & getrecommendations! Published in 2023 at "Rheumatology"
DOI: 10.1093/rheumatology/kead104.256
Abstract: Methotrexate (MTX) is a widely used DMARD for which routine blood monitoring is required to identify hepatotoxicity and bone marrow suppression. Despite routine monitoring and normal liver function tests some patients develop hepatic fibrosis. Transient… read more here.
Keywords: metavir score; monitoring; value; high median ... See more keywords